Current NHS consultant posts held
Clinical Oncologist
Kent Oncology
Maidstone and Tunbridge Wells
Maidstone
ME16 9QQ
Research interests
Cancer Genetics
Advanced Radiotherapy (IMRT/IGRT)
Biomarkers
PARP inhibitors (DNA repair)
Personal interests
Gynae Brachytherapy
Prostate Brachytherapy
SABR
Immunotherapy
Genetics
Awards received
GU ASCO Merit Award 2014
GU ASCO Merit Award 2015
RCR Ross Award 2015
Publications
C. Mikropoulos: Should we Perform Genetic Testing on Men with Metastatic Prostate Cancer?. Clinical Oncology 10/2016;, DOI:10.1016/j.clon.2016.10.004
Z Kote-Jarai, C Mikropoulos, DA Leongamornlert, T Dadaev, M Tymrakiewicz, E J Saunders, M Jones, S Jugurnauth-Little, K Govindasami, M Guy, F C Hamdy, J L Donovan, D E Neal, J A Lane, D Dearnaley, R A Wilkinson, E J Sawyer, A Morgan, A C Antoniou, R A Eeles: Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Annals of Oncology 01/2015; 26(4)., DOI:10.1093/annonc/mdv004
Christos Mikropoulos, Chee Goh, Daniel Leongamornlert, Zsofia Kote-Jarai, Rosalind Eeles: Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond. Future Oncology 08/2014; 10(9):1679-94., DOI:10.2217/fon.14.72
Rosalind Eeles, Christos Mikropoulos, Pardeep Kumar, Elena Castro, Elizabeth Bancroft, Natalie Taylor, Tohkir Dadaev, Zsofia Kote-Jarai: Abstract 262: The PROFILE feasibility study: Genetic prostate cancer risk stratification for targeted screening. The Journal of Urology 04/2014; 191(4):e714., DOI:10.1016/j.juro.2014.02.1952
Christos Mikropoulos, Elena Castro, Elizabeth Bancroft, Elizabeth Page, Natalie Taylor, Mahbubl Ahmed, Chee Leng Goh, Ros A. Eeles: Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study.. Journal of Clinical Oncology 02/2014; 32(4_suppl):8-8., DOI:10.1200/jco.2014.32.4_suppl.8
Christos Mikropoulos, Rosalind A Eeles: IMPACT Study: Targeted prostate cancer screening. The Oncologist 08/2013; 18(8):e28., DOI:10.1634/theoncologist.2013-0221
C Powell, C Mikropoulos, S.B. Kaye, C.M. Nutting, S.A. Bhide, K Newbold, K.J. Harrington: Preclinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. Cancer Treatment Reviews 11/2010; 36(7):566-75., DOI:10.1016/j.ctrv.2010.03.003
A S Strimpakos, D Cunningham, C Mikropoulos, I Petkar, Y Barbachano, I Chau: The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy. Annals of Oncology 10/2009; 21(5):1013-9., DOI:10.1093/annonc/mdp449.
